Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Vascular Prospects Aid 23% Stock Gain In 2006 – Index Up 5.7%

Jan 15 2007

Related Content

Guidant’s Problems Go Beyond Bad Communication – Boston Scientific CEO

Jul 03 2006

Abbott Makes First Xience Submission To FDA As Guidant Biz Boosts Sales

Jul 24 2006

Conor Ramps Up Production Of CoStar Stent To Prep For U.S. Launch

Jul 31 2006

J&J/Cordis Acquisition Ensures Place In Vascular Closure Arena

Jul 17 2006

Biomet Accepts $10.9 Bil. Private Equity Buyout To Stay Independent

Jan 01 2007

J&J Gains Next-Gen CoStar Stent Through $1.4 Bil. Conor Purchase

Nov 20 2006

Remotely Monitored ICDs Propel Medtronic’s 6% Market Share Gain

Nov 27 2006

Abbott Drops ZoMaxx Stent In Favor Of Xience On Trial Results Slated For TCT

Oct 09 2006

Abbott Xience Stent Int’l Launch Feedback “Positive” As Firm Builds Capacity

Oct 23 2006

Abbott Hits The Jackpot With Boston Scientific’s Acquisition Of Guidant

Jan 30 2006

Boston Scientific Stung With Across-The-Board Corporate Warning Letter

Jan 30 2006

CMS’ Change Of Heart On Inpatient Rule Is Positive News For Cardiac Firms

Aug 07 2006

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window